Skip to main content
Clinical Trials/IRCT201611306699N3
IRCT201611306699N3
Completed
未知

Therapeutic effect of intra tympanic injection of Dexamethasone-Hyaluronic acid combination in comparison with intra tympanic Dexamethasone in sudden sensorineural hearing loss

Vice Chancellor for Research, Isfahan University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Condition 1: Hearing loss. Condition 2: Sudden hearing loss.
Sponsor
Vice Chancellor for Research, Isfahan University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research, Isfahan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria consisted of unilateral hearing loss (occurring within 72 hours), the hearing threshold average greater than 50 dB, symptoms appearance within 7 days from our intervention, patient's pure tone audiogram at frequencies 250 500, 1000, 2000, 4000 and 8000 Hz, age range 18\-80 years, lack of acoustic tumor, middle ear diseases, autoimmune diseases, vestibular problem (Menier disease\&..), cardiovascular disorders and diabetes, no history of ear surgery and the patient’s consent to participate in the study.
  • Meanwhile patient’s refusal to attend on time for follow up visits, any limitation to inject intra tympanum via external auditory canal such as stenosis, anatomical deformities and external and middle ear infections were considered as exclusion criteria.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials